Amgen (AMGN) Stock Fell After Some Concerns Regarding The Released Clinical Data

By Yahoo! Finance | Jun 12, 2024 at 03:39 AM EST

Carillon Tower Advisers reported on the Carillon Eagle Growth & Income Fund's performance in the first quarter of 2024, noting the S&P 500's strong start. The fund highlighted Amgen Inc. as a key stock pick, with a one-month return of -3.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.